{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T22:33:27Z","timestamp":1710887607620},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,1,8]],"date-time":"2011-01-08T00:00:00Z","timestamp":1294444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s10620-010-1526-5","type":"journal-article","created":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T05:26:55Z","timestamp":1294378015000},"page":"1848-1852","source":"Crossref","is-referenced-by-count":10,"title":["Treatment of Genotype 4 Hepatitis C Recurring After Liver Transplantation Using a Combination of Pegylated Interferon Alfa-2a and Ribavirin"],"prefix":"10.1007","volume":"56","author":[{"given":"Waleed","family":"Al-hamoudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazem","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal","family":"Abaalkhail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaser","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasser","family":"Al-Masri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naglaa","family":"Allam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Al-Sofayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem","family":"Khalaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Al-Sebayel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Al-jedai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Abdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,8]]},"reference":[{"key":"1526_CR1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199603283341302","volume":"334","author":"EJ Gane","year":"1996","unstructured":"Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996;334:815\u2013820.","journal-title":"N Engl J Med"},{"key":"1526_CR2","doi-asserted-by":"crossref","unstructured":"Samuel D, Forns X, Berenguer M, et al. Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12\u201314, 2006). J Hepatol. 2006;45(1):127\u2013143.","DOI":"10.1016\/j.jhep.2006.05.001"},{"key":"1526_CR3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.510290122","volume":"29","author":"M Prieto","year":"1999","unstructured":"Prieto M, Berenguer M, Ray\u00f3n JM, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology. 1999;29:250\u2013256.","journal-title":"Hepatology"},{"key":"1526_CR4","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1053\/jlts.2002.34968","volume":"8","author":"RJ Firpi","year":"2002","unstructured":"Firpi RJ, Abdelmalek MF, Soldevila-Pico C, et al. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C. Liver Transpl. 2002;8:1000\u20131006.","journal-title":"Liver Transpl"},{"key":"1526_CR5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/00007890-200103150-00019","volume":"71","author":"ME Vera De","year":"2001","unstructured":"De Vera ME, Smallwood GA, Rosado K, et al. Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation. Transplantation. 2001;71:678\u2013686.","journal-title":"Transplantation"},{"key":"1526_CR6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/jlts.2001.22447","volume":"7","author":"DV Gopal","year":"2001","unstructured":"Gopal DV, Rabkin JM, Berk BS, et al. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin. Liver Transpl. 2001;7:181\u2013190.","journal-title":"Liver Transpl"},{"key":"1526_CR7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1478-3231.2008.01930.x","volume":"29","author":"SM Kamal","year":"2009","unstructured":"Kamal SM. Hepatitis C genotype 4 therapy: increasing options and improving outcomes. Liver Int. 2009;29:39\u201348.","journal-title":"Liver Int"},{"key":"1526_CR8","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/S1542-3565(05)00711-1","volume":"3","author":"MH Nguyen","year":"2005","unstructured":"Nguyen MH, Keeffe EB. Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. Clin Gastroenterol Hepatol. 2005;3:S97\u2013S101.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1526_CR9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/jhep.2000.8438","volume":"32","author":"F Abdel-Aziz","year":"2000","unstructured":"Abdel-Aziz F, Habib M, Mohamed MK, et al. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology. 2000;32:111\u2013115.","journal-title":"Hepatology"},{"key":"1526_CR10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1086\/315786","volume":"182","author":"SC Ray","year":"2000","unstructured":"Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis. 2000;182:698\u2013707.","journal-title":"J Infect Dis"},{"key":"1526_CR11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1096-9071(199905)58:1<44::AID-JMV6>3.0.CO;2-U","volume":"58","author":"OA Shobokshi","year":"1999","unstructured":"Shobokshi OA, Serebour FE, Skakni L, Al-Saffy YH, Ahdal MN. Hepatitis C genotypes and subtypes in Saudi Arabia. J Med Virol. 1999;58:44\u201348.","journal-title":"J Med Virol"},{"key":"1526_CR12","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1099\/0022-1317-75-9-2393","volume":"75","author":"L-Z Xu","year":"1994","unstructured":"Xu L-Z, Larzul D, Delaporte E, Br\u2032echot C, Kremsdorf D. Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon). J Gen Virol. 1994;75:2393\u20132398.","journal-title":"J Gen Virol"},{"key":"1526_CR13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1099\/vir.0.80409-0","volume":"86","author":"F Nicot","year":"2005","unstructured":"Nicot F, Legrand-Abravanel F, Sandres-Saune K, et al. Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France. J Gen Virol. 2005;86:107\u2013114.","journal-title":"J Gen Virol"},{"key":"1526_CR14","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/jmv.20706","volume":"78","author":"N Fernandez-Arcas","year":"2006","unstructured":"Fernandez-Arcas N, Lopez-Siles J, Trapero S, et al. High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): phylogenetic and epidemiological analyses. J Med Virol. 2006;78:1429\u20131435.","journal-title":"J Med Virol"},{"key":"1526_CR15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1034\/j.1600-0676.2000.020004335.x","volume":"20","author":"A Koshy","year":"2000","unstructured":"Koshy A, Marcellin P, Martinot M, Madda JP. Improved response to ribavirin interferon combination compared with interferon alone in patients with type 4 chronic hepatitis C without cirrhosis. Liver. 2000;20:335\u2013339.","journal-title":"Liver"},{"key":"1526_CR16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1478-3231.2004.0976.x","volume":"24","author":"FZ Alfaleh","year":"2004","unstructured":"Alfaleh FZ, Hadad Q, Khuroo MS, et al. Peginterferon a-2b plus ribavirin compared with interferon a-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4. Liver Int. 2004;24:568\u2013574.","journal-title":"Liver Int"},{"key":"1526_CR17","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/hep.21917","volume":"46","author":"S Kamal","year":"2007","unstructured":"Kamal S, Kamary S, Shardell M, et al. Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: the role of rapid and early virologic response. Hepatology. 2007;46:1732\u20131740.","journal-title":"Hepatology"},{"key":"1526_CR18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/0256-4947.51796","volume":"29","author":"H Mudawi","year":"2009","unstructured":"Mudawi H, Helmy A, Kamel Y, et al. Recurrence of hepatitis C virus genotype 4 infection following orthotopic liver transplantation: natural history and predictors of outcome. Ann Saudi Med. 2009;29:91\u201397.","journal-title":"Ann Saudi Med"},{"key":"1526_CR19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10595-002-2537-5","volume":"33","author":"H Sugo","year":"2003","unstructured":"Sugo H, Balderson GA, Crawford DH, et al. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation. Surg Today. 2003;33:421\u2013425.","journal-title":"Surg Today"},{"key":"1526_CR20","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1053\/jlts.2003.50164","volume":"9","author":"MH Wali","year":"2003","unstructured":"Wali MH, Heydtmann M, Harrison RF, Gunson BK, Mutimer DJ. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4. Liver Transpl. 2003;9:796\u2013804.","journal-title":"Liver Transpl"},{"key":"1526_CR21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-140-5-200403020-00033","volume":"140","author":"S Zeuzem","year":"2004","unstructured":"Zeuzem S. Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well? Ann Intern Med. 2004;140:370\u2013381.","journal-title":"Ann Intern Med"},{"key":"1526_CR22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1399-3062.2008.00359.x","volume":"11","author":"S Dinges","year":"2009","unstructured":"Dinges S, Morard I, Heim M, et al. Pegylated interferon-alpha2a\/ribavirin treatment of recurrent hepatitis C after liver transplantation. Transpl Infect Dis. 2009;11:33\u201339.","journal-title":"Transpl Infect Dis"},{"key":"1526_CR23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2893.2008.01019.x","volume":"15","author":"E Xirouchakis","year":"2008","unstructured":"Xirouchakis E, Triantos C, Manousou P, et al. Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies. J Viral Hepat. 2008;15:699\u2013709.","journal-title":"J Viral Hepat"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1526-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-010-1526-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1526-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T17:09:45Z","timestamp":1559927385000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-010-1526-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,8]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["1526"],"URL":"https:\/\/doi.org\/10.1007\/s10620-010-1526-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,8]]}}}